Skip to main content

Table 1 Baseline characteristics of the study population

From: Association of visceral adiposity index with incident nephropathy and retinopathy: a cohort study in the diabetic population

 

Overall (n = 8948)

DN- (n = 8481)

DN + (n = 467)

P value

DR- (n = 8858)

DR + (n = 90)

P value

Age, years

53.35 (14.66)

52.42 (14.19)

70.27 (12.70)

 < 0.001

53.33 (14.70)

55.88 (10.25)

0.101

Men, n (%)

6154 (68.8)

5825 (68.7)

329 (70.4)

0.453

6074 (68.6)

80 (88.9)

 < 0.001

Education, n (%)

 Primary school or below

955 (10.7)

900 (10.6)

55 (11.8)

0.320

939 (10.6)

16 (17.8)

0.003

 Middle school

6054 (67.7)

5731 (67.6)

323 (69.2)

 

5988 (67.6)

66 (73.3)

 

 High school or above

1939 (21.7)

1850 (21.8)

89 (19.1)

 

1931 (21.8)

8 (8.9)

 

Physical activity (n, %)

3755 (42.0)

3546 (41.8)

209 (44.8)

0.228

3721 (42.0)

34 (37.8)

0.483

Current smoking (n, %)

2709 (30.3)

2592 (30.6)

117 (25.1)

0.013

2668 (30.1)

41 (45.6)

0.002

Current drinking (n, %)

5067 (56.6)

4832 (57.0)

235 (50.3)

0.005

5013 (56.6)

54 (60.0)

0.588

BMI, kg/m2

25.48 (3.36)

25.46 (3.37)

25.86 (3.27)

0.012

25.47 (3.37)

26.23 (3.15)

0.033

WC, cm

87.32 (10.18)

87.17 (10.18)

90.02 (9.75)

 < 0.001

87.27 (10.18)

91.70 (8.33)

 < 0.001

Hypertension (n, %)

3607 (40.3)

3262 (38.5)

345 (73.9)

 < 0.001

3559 (40.2)

48 (53.3)

0.015

Dyslipidaemia (n, %)

3328 (37.2)

3138 (37.0)

190 (40.7)

0.120

3282 (37.1)

46 (51.1)

0.008

Antidiabetic (n, %)

1198 (13.4)

1075 (12.7)

123 (26.3)

 < 0.001

1128 (12.7)

70 (77.8)

 < 0.001

Antihypertensive (n, %)

732 (8.2)

659 (7.8)

73 (15.6)

 < 0.001

728 (8.2)

4 (4.4)

0.268

Lipid lowering (n, %)

492 (5.5)

438 (5.2)

54 (11.6)

 < 0.001

488 (5.5)

4 (4.4)

0.835

Fasting glucose, mmol/L

5.31 [4.94,5.94]

5.30 [4.93,5.93]

5.50 [5.04,6.32]

 < 0.001

5.30 [4.93,5.91]

8.32 [7.21,12.07]

 < 0.001

HbA1c, %

5.57 [5.31,5.96]

5.56 [5.30,5.94]

5.80 [5.54,6.24]

 < 0.001

5.57 [5.31,5.95]

7.53 [6.54,9.09]

 < 0.001

Triglycerides, mmol/L

1.27 [0.89,1.87]

1.27 [0.89,1.88]

1.21 [0.91,1.77]

0.479

1.27 [0.89,1.87]

1.38 [0.96,2.19]

0.143

HDL-C, mmol/L

1.26 [1.06,1.53]

1.26 [1.06,1.53]

1.25 [1.05,1.56]

0.945

1.26 [1.06,1.53]

1.17 [0.97,1.34]

 < 0.001

VAI

1.46 [0.90,2.37]

1.45 [0.90,2.36]

1.76 [1.03,2.80]

0.043

1.46 [0.89,2.37]

1.45 [0.95,2.32]

0.984

CVAI

112.60 [77.19,143.17]

111.07 [75.68,141.98]

136.62 [107.49,160.81]

 < 0.001

112.44 [76.88,143.07]

125.61 [104.48,154.95]

 < 0.001

  1. Data are the mean (SD), median [IQR] or number (%)
  2. To convert fasting glucose to mg/dL, multiply by 18; triglycerides to mg/dL multiply by 28.25
  3. DR diabetic retinopathy, DN diabetic nephropathy, BMI body mass index, HbA1c glycated haemoglobin, HDL-C high-density lipoprotein cholesterol, VAI visceral adiposity index, CVAI Chinese visceral adiposity index